EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access

Minimal Impact on the Resistome of Children in Botswana After Azithromycin Treatment for Acute Severe Diarrheal Disease

Allison K Guitor iD, Anna Katyukhina, Margaret Mokomane, Kwana Lechiile, David M Goldfarb, Gerard D Wright iD, Andrew G McArthur, Jeffrey M Pernica

The Journal of Infectious Diseases · 2024

DOI: 10.1093/infdis/jiae049 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift The Journal of Infectious Diseases, 2024. Verfasst von Allison K Guitor und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, Ontario, Canada. Hauptthemen laut MEDLINE: Azithromycin, Diarrhea, Anti-Bacterial Agents, Gastrointestinal Microbiome. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: CIHR, McMaster University, Cisco Systems Canada.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Macrolide antibiotics, including azithromycin, can reduce under 5 years of age mortality rates and treat various infections in children in sub-Saharan Africa. These exposures, however, can select for antibiotic-resistant bacteria in the gut microbiota.

Methods

Our previous randomized controlled trial (RCT) of a rapid-test-and-treat strategy for severe acute diarrheal disease in children in Botswana included an intervention (3-day azithromycin dose) group and a control group that received supportive treatment. In this prospective matched cohort study using stools collected at baseline and 60 days after treatment from RCT participants, the collection of antibiotic resistance genes or resistome was compared between groups.

Results

Certain macrolide resistance genes increased in prevalence by 13%–55% at 60 days, without differences in gene presence between the intervention and control groups. These genes were linked to tetracycline resistance genes and mobile genetic elements.

Conclusions

Azithromycin treatment for bacterial diarrhea for young children in Botswana resulted in similar effects on the gut resistome as the supportive treatment and did not provide additional selective pressure for macrolide resistance gene maintenance. The gut microbiota of these children contains diverse macrolide resistance genes that may be transferred within the gut upon repeated exposures to azithromycin or coselected by other antibiotics. Clinical Trials Registration NCT02803827.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AzithromycinDiarrheaAnti-Bacterial AgentsGastrointestinal MicrobiomeHumansBotswanaChild, PreschoolInfantProspective StudiesFemaleMaleDrug Resistance, BacterialFecesBacteria

Stichwörter der Autor:innen

antibiotic resistanceazithromycinbacterial diarrhea

Substanzen

AzithromycinAnti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, Ontario, Canada.
  • Michael G. DeGroote Institute for Infectious Disease Research, McMaster University, Hamilton, Ontario, Canada.
  • David Braley Centre for Antibiotic Discovery, McMaster University, Hamilton, Ontario, Canada.
  • School of Allied Health Professions, Faculty of Health Sciences, University of Botswana, Gaborone, Botswana.
  • Botswana National Health Laboratory, Gaborone, Botswana.
  • Botswana-University of Pennsylvania Partnership, Gaborone, Botswana.

ORCID-Profile: Allison K Guitor, Gerard D Wright

Förderung

  • CIHR
  • McMaster University
  • Cisco Systems Canada
  • Hewlett Packard Enterprise
  • Pure Storage
  • Grand Challenges Canada
  • bioMérieux
  • Canadian Institutes of Health Research

Zitieren

APA

Guitor, A. K., Katyukhina, A., Mokomane, M., Lechiile, K., Goldfarb, D. M., Wright, G. D., McArthur, A. G., & Pernica, J. M. (2024). Minimal Impact on the Resistome of Children in Botswana After Azithromycin Treatment for Acute Severe Diarrheal Disease. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiae049

Vancouver

Guitor AK, Katyukhina A, Mokomane M, Lechiile K, Goldfarb DM, Wright GD, et al. Minimal Impact on the Resistome of Children in Botswana After Azithromycin Treatment for Acute Severe Diarrheal Disease. The Journal of Infectious Diseases. 2024. doi:10.1093/infdis/jiae049

BibTeX
@article{Guitor2024,
  author = {Guitor, Allison K and Katyukhina, Anna and Mokomane, Margaret and Lechiile, Kwana and Goldfarb, David M and Wright, Gerard D and McArthur, Andrew G and Pernica, Jeffrey M},
  title = {Minimal Impact on the Resistome of Children in Botswana After Azithromycin Treatment for Acute Severe Diarrheal Disease},
  journal = {The Journal of Infectious Diseases},
  year = {2024},
  doi = {10.1093/infdis/jiae049}
}
Kostenlos starten →